9.00 Conference opening
Direct to Patient Strategy
9.20 - 10.20
Learn how leading companies are building direct relationships with patients to improve access, adherence, and long-term engagement.
This block will highlight real-world case studies and proven tactics using digital insights, outreach, and education to support earlier diagnosis, smoother onboarding, and continuity of care outside traditional clinical pathways.
This block will highlight real-world case studies and proven tactics using digital insights, outreach, and education to support earlier diagnosis, smoother onboarding, and continuity of care outside traditional clinical pathways.
Speakers
09.20
Piotr Ziarek
CEE Digital Commerce
Activation Manager
09.40
Francis Kiss
Specialized Nutrition Director CEE, Danone
From prescription to Connection:
Rethinking how we engage patients in Medical Nutrition.
Rethinking how we engage patients in Medical Nutrition.
10.00
Razvan Nanulescu
Franchise Head, PPH-PMED, Vaccines, Central South Europe, Sanofi
Patients First, Not Last:
Reimagining Patient Engagement- Lessons from Our Vaccine Journey & Beyond
Reimagining Patient Engagement- Lessons from Our Vaccine Journey & Beyond
10.20 - 10.40 Coffee Break & Networking
How to Drive a Treatment Switch
10.40 - 12.20
Switching from established treatments to innovative alternatives is rarely straightforward.
This track explores practical strategies to accelerate adoption—by meeting patients where they are, supporting meaningful dialogue with physicians, and aligning healthcare stakeholders around better outcomes.
This track explores practical strategies to accelerate adoption—by meeting patients where they are, supporting meaningful dialogue with physicians, and aligning healthcare stakeholders around better outcomes.
Speakers
10.40
Zoltan Jakab
Regional Vice President, Central Eastern Europe, Abbvie
When Innovation Meets the System:
Making Treatment Switches Happen
Making Treatment Switches Happen
11.00
Miro Hutnan
AI Product Specialist, STAPRO
Unlocking Hospital Data for Pharmaceutical Studies
11.20
Lubos Misik
Project Manager, grandaliro
11.40
Panel discussion:
How will AI driven automation reshape Leadership, decision-Making, and Careers in future Pharma?
Jan Szolos, Lucie Svobodova,
Martin Majernik
12.20 - 13.30 Lunch & Networking
Regional Launch Tactics
13.30 - 14.50
A successful launch in any region demands more than just localization—it calls for a smart balance between global strategy and local execution.
In this track, we’ll explore how to bridge that gap and build scalable campaigns that adapt to local nuances while delivering measurable results.
In this track, we’ll explore how to bridge that gap and build scalable campaigns that adapt to local nuances while delivering measurable results.
Speakers
13.30
Lucie Svobodova
Founder and Owner of A REG Solutions, A-REG
From Approval to Access:
Regulatory Affairs as a Launch Accelerator in Regional Markets
Regulatory Affairs as a Launch Accelerator in Regional Markets
14.10
Kostadin Kosev
Medical & Launch Excellence CEE, Novartis
The Paradox of CEE:
Between Privilege and Exclusion of small to mid-sized countries in effective communication
Between Privilege and Exclusion of small to mid-sized countries in effective communication
14.30
Panel discussion:
How Can CEE Compete with the Big 5 in European Healthcare Innovation?
Daniel Rankin, Tomasz Rudolf
14.50 - 15.10 Coffee Break & Networking
What’s Next After 2026
15.10 - 16.40
It’s hard to look beyond the next 12 months—but those who do will shape the future of healthcare.
This block offers a forward-looking perspective on innovation, digital transformation, and emerging technologies to help you design campaigns and strategies that stay ahead of the curve.
This block offers a forward-looking perspective on innovation, digital transformation, and emerging technologies to help you design campaigns and strategies that stay ahead of the curve.
Speakers
15.10
Jan Szolos
Chief Business Officer, QurieGen
Pharma 2030: The Technologies Turning R&D into Revenue
15.30
Daniel Rankin
Head of Strategy & Corporate Development, Sobi
The status of Biotech:
the European midcap perspective
the European midcap perspective
15.50
Tomasz Rudolf
Co-founder, Doctor.One
Pharma beyond the pill, care beyond the visits: how can we improve care paths for chronic patients?
16.40 - 22.00 After Party & Networking
Program 2024
08.50
Opening Remarks
Clinical Research
09.00
PharmDr. Adam Majcher Ph.D.
Postdoctoral Researcher
Clinical metabolomics and lipidomics
in personalized medicine
in personalized medicine
09.20
Mgr. Lenka Bešše, PhD
Group Leader
Drug repurposing in the era
of personalized treatment
of personalized treatment
09.40
MPharm. Pavlina Walter, MBA
Managing Director CEE / Head of Global Business Development
What problems do medical device
manufacturers face with AI?
manufacturers face with AI?
10.00
MVDr, Jindřich Šoltys, CSc.
Science and Research Manager
Organization of clinical trials and
biomedical research in Slovakia
biomedical research in Slovakia
10.20
Coffee & Networking
Business & Marketing
10.40
Michal Holaň, Daniel Varga
Performance Specialists
Trends not only in healthtech
marketing
marketing
11.00
Mgr. Viktor Dzurilla, MBA
International product manager & Slovak product manager
Is it possible to do marketing activities
with added social value?
with added social value?
11.20
PharmDr. Walter Scholz
Sales Manager Hematology
From leaflets to AI:
Evolution of pharmaceutical
marketing in Slovakia
Evolution of pharmaceutical
marketing in Slovakia
11.40
Panel Discussion:
What patients do when
they are not patients?
Dominike Illek, Martin Haranta, Lukáš Polakovič
12.20
Lunch & Networking
Hospitals & Primary Care
13.30
MUDr. Tatiana Izakovič, MHA, CIC
Hospital epidemiologist
The importance of measuring quality
indicators in healthcare
indicators in healthcare
14.10
MUDr. Matej Pribis
Co-Founder, Chief physician in representation
How to approach mental healthcare
in the 21st century?
in the 21st century?
14.30
Mgr. Miroslav Hutňan
Healthcare Innovation Manager
Bottlenecks and opportunities
in digital health technologies
in digital health technologies
14.50
Coffee & Networking
Start Ups
15.10
Miroslav Gašpárek MEng ACGI
Chief Executive Officer and Co-Founder
Can biotechnology industry be the next automotive for Slovakia?
15.30
Matěj Misař
Founder - Managing director
AI in diagnostics: The reality of Slovak
and Czech hospitals
and Czech hospitals
15.50
Panel Discussion:
Medical Technologies 2034 –
Where are we heading?
Matěj Misař, Lenka Bešše, Miroslav Gašparek, MIroslav Hutňan
16.40
After Party & Networking
Organized by
